www.cancerindetail.com

Nordion to divest targeted therapies business to BTG

May 27, 2013 | medicalphysicsweb.org

OTTAWA, ONTARIO, 23 May 2013 – Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced that it has entered into an agreement to divest... Read more...

Nordion BTG TheraSphere divest therapy targeted

Hepatitis C: Am I At Risk For Liver Cancer?

May 26, 2013 | hepatitiscnewdrugs.blogspot.cz

Hepatitis C: Am I At Risk For Liver Cancer? Offered on the blog today are a few studies that look at the risk for developing liver cancer in people who are - or who have been - infected with chronic hepatitis C. The CDC... Read more...

liver hepatitis cirrhosis HCV patient HCC C risk SVR cancer chronic liver-related fibrosis carcinoma hepatocellular Aleman

The 7 Most Obese US States

May 26, 2013 | drugpolicycentral.com

Arena's Belviq was approved in June -- just weeks before VIVUS' Qsymia -- but its debut has been on hold because of drug labeling by the Drug Enforcement Agency. Arena's Belviq was approved in June -- just weeks before VIVUS'... Read more...

obesity obese VIVUS drug SGLT2 Belviq cancer inhibitor complication weight-management Qsymia Sutent Nexavar Motley Forxiga Fool Arena 7

image

Consumption of Coffee Associated With Reduced Risk of Liver Cancer - A Meta-Analysis

May 26, 2013 | hepatitiscnewdrugs.blogspot.com

Consumption of Coffee Associated With Reduced Risk of Liver Cancer What does the latest scientific evidence say about the connection between coffee consumption and liver cancer? Does it offer protective benefits? May 23, 2013... Read more...

liver coffee consumption cancer meta-analysis study risk kahweol inverse

image

Trambax 100mg Inj 1ml

May 25, 2013 | matrixdirectindia.com

Within preferred embodiments of the invention, the composition should firmly adhere to the stent during storage and at the age of insertion, and should not be dislodged from the stent when the breadth is expanded from its... Read more...

stent biliary Р Trambax tumor Inj duct 1ml anti-angiogenic insertion bile passageway 100mg obstruction stents Pat no. carcinoma

image

Law Offices of Todd M. Garber Announces Investigation of Delcath Systems, Inc.

May 25, 2013 | fortmilltimes.com

The Law Offices of Todd M. Garber announces that it is investigating potential claims against Delcath Systems, Inc. (“Delcath” or the “Company”) (NASDAQ:DCTH) concerning possible violations of federal securities laws. The... Read more...

Delcath Garber Melblez Todd Law investigation

image

Health unit launches campaign to tackle binge drinking

May 25, 2013 | windsorstar.com

Windsor is notorious for its busy bar scene but the public health unit wants to tone the binge drinking down just a little in the interests of long-term health. People don’t necessarily think about how heavy drinking will... Read more...

drinking binge alcohol poster McBeth health consumption Goodstadt campaign bfantoni cirrhosis heavy unit cent Windsor-Essex cancer launch Windsor per liver

image

Deals Of The Week Ponders When $2.1 Billion Is A Steal

May 24, 2013 | invivoblog.blogspot.cz

With the oncology high season upon us and just about everyone in the industry scrambling to decode the secrets hidden in ASCO’s abstracts, we couldn’t help but stop and reflect on how at least one company got where it is in... Read more...

Medarex Zoetis Xellia Bristol Actavis GSK Novo elan BTG Pfizer BARDA deal Therasphere

image

Gary Null and Richard Gale – Seeds of Death: Understanding the Deception Behind GMOs

May 24, 2013 | prn.fm

Today the vast majority of foods in supermarkets contain genetically modified substances whose effects on our health are unknown. As a medical doctor, I can assure you that no one in the medical profession would attempt to... Read more...
All similar articles: 1848 »

GMO GM food GMOs Monsanto organic chemical pesticide agriculture health plant labelling labeling genetically farming crop soy seed

image

Exelixis Prepares for ASCO 2013, Stocks Stays Rangebound

May 24, 2013 | proactiveinvestors.com

One of the biopharmaceutical companies that has been lagging the stellar performance of its peers is Exelixis (NADSAQ: EXEL) , developer of the compound cabozantinib. Cabo, which was FDA approved last year for the treatment of... Read more...

Exelixis cabozantinib COMET-1 MTC ASCO COMETRIQ COMET-2 EXEL RCC trial 2013 indication HCC stock

CLSN - Celsion Corporation

May 24, 2013 | hotstockmarket.com

CLSN - Celsion Corporation - Page 2 Celsion: ThermoDox Didn't Meet Primary Endpoint in Primary Liver Cancer Study 3 days 10 hours 11 minutes ago - Dow Jones News By Melodie Warner Celsion Corp. (CLSN) said the combined use of... Read more...

Celsion CLSN ThermoDox HCC corporation HEAT cancer

No fear, just faith for family of child diagnosed with cancer

May 24, 2013 | yourgv.com

All young Seanan Whitaker knew was something bad was going on in his stomach. He had no idea he was battling for his life. His parents, Sean and Lataya Whitaker of Manassas, noticed their son’s stomach swelling and immediately... Read more...

McKenzie Whitaker cancer diagnose faith chemo Seanan liver stomach fear Halifax transplant Seaniya parent family

image

St. Luke’s to host International Symposium on Gastroenterology and Hepatology

May 24, 2013 | gmanews.tv

International experts in the fields of gastroenterology and hepatology will be speaking at the 4th Liver and 2nd Gastroenterology International Symposium hosted by St. Luke’s Institute of Digestive and Liver Diseases (IDLD) on... Read more...

Gastroenterology Hepatology Luke Symposium Dr. International Medical St. Gish host esophagealvarices IDLD Luke’s-Global 7239574 7230101 Liver

Viscera transplant operations at nighttime end in success

May 24, 2013 | talkvietnam.com

Doctors at Viet-German Hospital in Hanoi were successful in conducting three simultaneous kidney and liver transplant operations on the night of May 21, thus giving a renewed life to three people suffering from life threatening... Read more...

Saigon-Gpdaily transplant liver operation Quyet kidney Viet-German Hanoi recipient physician Tien Hepatitis

image

GBK & Sparkling Hill Resort Hosted a Luxury Lounge in Honor of the 2013 Cannes Film Festival at...

May 24, 2013 | timesunion.com

GBK & Sparkling Hill Resort Hosted a Luxury Lounge in Honor of the 2013 Cannes Film Festival at the Hollywood Boudoir™ Villa May 17th-20th 2013, Cannes France Distinguished guests received a five night Escape from their hectic... Read more...

GBK GBK&Sparkling Cannes resort Hill lounge gift festival luxury

image

Dedicated runner thought he was in perfect health

May 23, 2013 | stltoday.com

Home • St. Charles. Occupation • Area director of operations for Spectrum Retirement of Missouri. What he did • While battling colon and rectal cancer, he has continued distance running, but now he does it to fight the disease.... Read more...

Harry Jackson Jr Heigl tumor Siteman chemo runner cancer colon resection meter liver www.stlouisseniorolympics.org health fatigue rectal doctor gorilla Spectrum sometimes

Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver...

May 23, 2013 | checkorphan.org

Cellular Biomedicine Group announced that it has achieved half of the enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of TC-DC (Tumor Stem Cell... Read more...

TC-DC cell enrollment therapy Biomedicine cellular trial clinical HCC liver tumor patient CBMG phase immune recurrence

image

Jennerex Completes $21.6 Million Private Placement

May 23, 2013 | firmenpresse.de

SAN FRANCISCO, CA -- (Marketwired) -- 05/23/13 -- Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic... Read more...

Pexa-Vec Jennerex tumor $21.6 cancer oncolytic Phase TRAVERSE

image

Adding Cetuximab to Chemotherapy Increases Resection Rates of Colorectal Liver Metastases and...

May 23, 2013 | onclive.com

The addition of cetuximab to chemotherapy as first-line treatment of KRAS wild-type unresectable colorectal liver metastases resulted in a higher rate of resection and longer survival than chemotherapy alone Read more...

resection cetuximab liver metastasis patient chemotherapy CLM CLMs chemotherapy-alone tumor study adding PFS chemotherapy-only OS

image

Jennerex Completes $21.6 Million Private Placement

May 23, 2013 | newsblaze.com

Jennerex Biotherapeutics, Inc., a private, clinical-stage biotechnology company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced that it has... Read more...

Jennerex $21.6 placement tumor Pexa-Vec private oncolytic complete immunotherapy

Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc

May 23, 2013 | sectorpublishingintelligence.co.uk

World News: 07:00 GMT Thursday 23rd May 2013. [Nordion Inc. via Businesswire] Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced... Read more...

Nordion BTG TheraSphere Therapies Targeted transaction plc www.nordion.com

image

BTG builds interventional medicine platform with deals

May 23, 2013 | expatnewsletter.net

LONDON | Thu May 23, 2013 8:01am BST LONDON (Reuters) – Britain’s BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an... Read more...

Expatnewsletter.Net BTG interventional medicine Nordion bead deal Therasphere EkoSonic clot Varisolve

image

Hepatocellular Carcinoma: Imaging Patterns on Gadoxetic Acid-enhanced MR Images and Their Value...

May 23, 2013 | rsnajnls.org

Purpose: To investigate the patterns of imaging appearance of hepatocellular carcinoma (HCC) on gadoxetic acid–enhanced magnetic resonance (MR) images and to assess their potential value as prognostic markers of HCC associated... Read more...

Jin Woo Choi HCCs MR imaging J.M.L. J.W.C. carcinoma HBP gadoxetic pattern image P hyperintensity B.I.C. .0001 J.H.Y. TTR iso manuscript HCC log-rank tumor

ReformedBroker: Land of the Lost http://t.co/wANWVXPzK8

May 22, 2013 | redliontrader.com

Post navigation ← felixsalmon: A timely reminder that it’s not just Apple: they all do it. http://t.co/3JQYNIMiAu There’s A Huge Flaw In Yahoo’s Monetization Plan For Tumblr (YHOO) → PALO ALTO, Calif., May 22, 2013 /PRNewswire/... Read more...

Twitterfeed Enzoani CBMG TC-DC GEDC patient cell t.co Behrmann therapy Biomedicine Yenter

Science: Researchers from Peking University Cancer Hospital and Institute Describe Findings in...

May 22, 2013 | newsrx.com

By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on Science. According to news reporting originating from Beijing, People's Republic of China, by NewsRx correspondents, research... Read more...

1B50-1 a2d1 Beijing TICs institute cancer science HCC researcher finding university www.elsevier.com hospital Proteins describe Calcium

The ART of decision making: Retreatment with transarterial chemoembolization in patients with...

May 22, 2013 | wiley.com

Article first published online: 3 MAY 2013 Hepatology Early View (Online Version of Record published before inclusion in an issue) How to Cite Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl,... Read more...

Wolfgang Sieghart TACE ART transarterial chemoembolization retreatment Peck-Radosavljevic Hepatology Pharma Schering Heinzl Trauner Sieghart M. cohort patient grant Vienna ≥2.5

image

Roche Unveils the cobas® 6800 and cobas® 8800 Systems at International Congresses

May 22, 2013 | tissuepathology.com

Roche is proud to unveil the fully integrated, highly automated cobas® 6800 and cobas® 8800 Systems, the next generation of molecular diagnostic platforms that will revolutionize the way laboratories operate. The cobas® 6800... Read more...

Keith J. Kaplan cobas 6800 8800 Roche infection PCR hepatitis Systems B19 Virus WNV CMV assay HAV blood

image

Natural Sciences Repository Publishes New Information on Liver Disease and on Disease Resistance

May 22, 2013 | prweb.com

The novel Natural Sciences Repository aims to provide reliable information on various areas of scientific interest in the simplest words and terms possible. The site has now added new scientific information on liver disease... Read more...

disease liver resistance category organism repository contain scientific

image

4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in...

May 21, 2013 | pressebox.de

Planegg-Martinsried, Germany, 21.05.2013 - . - Phase I/II study to investigate safety and efficacy of resminostat/sorafeni­b combination vs. sorafenib alone as first-line treatment of advanced liver cancer... Read more...

resminostat 4SC Yakult Honsha sorafenib HCC Phase cancer clinical II

Treating Cancer - Cannabis and Cannabinoids

May 20, 2013 | newsvine.com

This information may be useful for people that have cancer or for people that have a loved one with cancer. Cannabinoids are useful in treating the side effects of cancer and for cancer treatment. Cannabinoids are active... Read more...

National Cancer Institute Cannabinoids cancer cell delta-9-THC cannabinoid receptor cannabidiol effect